RxDoctor Payments Data

Daniel Eddelman, MD

Neurological Surgery · Indianapolis, INNPI 1861807844

Payments from drug & device makers

What this record shows

This record is dominated by grants: $44,996 of the $48,961 with a category attached, or 91.9%. Olympus Corporation Of The Americas accounts for 91.9% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2022 at $25,108 and has fallen 99.1% since, to $229 in 2025. Among neurological surgery clinicians in IN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$48,961in general payments, 2019–2025

Across 76 payments — averaging $644.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Olympus Corporation Of The Americas$45K
  • Stryker$3K
  • Medtronic$449
  • Icotec Medical Inc.$164
  • Johnson & Johnson$121
  • Zimmer Biomet$107
  • plus $214 from 3 others

What the payments were for

  • Grants$44,99692%
  • Travel & lodging$1,9344%
  • Food & beverage$1,9254%
  • Education$1050%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$48,961 in reported general payments places this provider in the 90th percentile of 112 neurological surgery providers in Indiana.

See all neurological surgery providers in Indiana

Medicare billing

Part B allowed, 2024
$97,139
Medicare patients
152
Services billed
313

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen16$196
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen18$166
Tizanidine Hcl14$60
Cyclobenzaprine Hcl15$57

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Indianapolis

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →